M&A Deal Summary |
|
|---|---|
| Date | 1999-02-09 |
| Target | Diversified Pharmaceutical Services |
| Sector | Healthcare Services |
| Buyer(s) | Express Scripts Holding Co. |
| Sellers(s) | GSK |
| Deal Type | Divestiture |
| Deal Value | 700M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1986 |
| Sector | Healthcare Services |
| Employees | 25,900 |
| Revenue | 100.1B USD (2017) |
Express Scripts Holding Co. is a provider of integrated pharmacy-benefit management services. Services include network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. Express Scripts Holding Co. was formed in 1986 and is based in St. Louis, Missouri.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 15 |
| Sector: Healthcare Services M&A | 2 of 9 |
| Type: Divestiture M&A Deals | 2 of 4 |
| State: Montana M&A | 1 of 1 |
| Country: United States M&A | 2 of 15 |
| Year: 1999 M&A | 1 of 1 |
| Size (of disclosed) | 4 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1998-04-01 |
ValueRx
United States ValueRx provides healthcare services. |
Buy | $445M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2001-06-12 |
IVTx
St. Louis, Missouri, United States IVTx, Inc. is a provider of infusion services in the Baltimore, Newark, Dallas, Houston, Philadelphia, and St. Louis areas. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1715 |
| Sector | Life Science |
| Employees | 68,629 |
| Revenue | 31.4B GBP (2024) |
GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 24 |
| Sector: Healthcare Services M&A | 1 of 3 |
| Type: Divestiture M&A Deals | 1 of 23 |
| State: Montana M&A | 1 of 1 |
| Country: United States M&A | 1 of 4 |
| Year: 1999 M&A | 1 of 1 |
| Size (of disclosed) | 4 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1995-01-26 |
Affymax
Cupertino, California, United States Affymax is a biopharmaceutical company focused on anemia in kidney disease and cancer. Affymax was established in 2001 and is based in Cupertino, California. |
Buy | $533M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2000-01-17 |
SmithKline Beecham
Brentford, United Kingdom SmithKline Beecham is a global pharmaceutical company based in Brentford, England. |
Buy | $75.7B |
